UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

The RNA methyltransferase METTL16 enhances cholangiocarcinoma growth through PRDM15-mediated FGFR4 expression

Journal of experimental & clinical cancer research, 2023-10, Vol.42 (1), p.263-263, Article 263

2023

Volltextzugriff (PDF)

The histone lysine acetyltransferase KAT2B inhibits cholangiocarcinoma growth: evidence for interaction with SP1 to regulate NF2-YAP signaling

Journal of experimental & clinical cancer research, 2024-04, Vol.43 (1), p.117-117, Article 117

2024

Volltextzugriff (PDF)

SNRPB is a mediator for cellular response to cisplatin in non-small-cell lung cancer

Medical oncology (Northwood, London, England), 2021-05, Vol.38 (5), p.57, Article 57

2021

Volltextzugriff (PDF)

Complete replication of hepatitis B virus and hepatitis C virus in a newly developed hepatoma cell line

Proceedings of the National Academy of Sciences - PNAS, 2014-04, Vol.111 (13), p.E1264-E1273

2014

Volltextzugriff (PDF)

ISG12a Restricts Hepatitis C Virus Infection through the Ubiquitination-Dependent Degradation Pathway

Journal of virology, 2016-08, Vol.90 (15), p.6832-6845

2016

Volltextzugriff (PDF)

Pulsed low-dose rate radiotherapy has an improved therapeutic effect on abdominal and pelvic malignancies

Journal of Zhejiang University. B. Science, 2021-09, Vol.22 (9), p.774-781

2021

Volltextzugriff (PDF)

MiR-942 mediates hepatitis C virus-induced apoptosis via regulation of ISG12a

PloS one, 2014-04, Vol.9 (4), p.e94501

2014

Volltextzugriff (PDF)

Inhibition of hepatitis C virus infection by DNA aptamer against NS2 protein

PloS one, 2014-02, Vol.9 (2), p.e90333

2014

Volltextzugriff (PDF)

Improving radio-chemotherapy efficacy of prostate cancer by co-deliverying docetaxel and dbait with biodegradable nanoparticles

Artificial cells, nanomedicine, and biotechnology, 2020-01, Vol.48 (1), p.305-314

2020

Volltextzugriff (PDF)

Innate host response in primary human hepatocytes with hepatitis C virus infection

PloS one, 2011-11, Vol.6 (11), p.e27552-e27552

2011

Volltextzugriff (PDF)

2-octynoic acid inhibits hepatitis C virus infection through activation of AMP-activated protein kinase

PloS one, 2013-05, Vol.8 (5), p.e64932

2013

Volltextzugriff (PDF)

Inhibition of hepatitis C virus infection by NS5A-specific aptamer

Antiviral research, 2014-06, Vol.106, p.116-124

2014

Volltextzugriff (PDF)

SNRPB promotes the tumorigenic potential of NSCLC in part by regulating RAB26

Cell death & disease, 2019-09, Vol.10 (9), p.667-11, Article 667

2019

Volltextzugriff (PDF)

Systematic pan‐cancer analysis identifies RBM39 as an immunological and prognostic biomarker

Journal of cellular and molecular medicine, 2022-09, Vol.26 (18), p.4859-4871

2022

Volltextzugriff (PDF)

Positive feedback loop between cancer stem cells and angiogenesis in hepatocellular carcinoma

Cancer letters, 2016-09, Vol.379 (2), p.213-219

2016

Volltextzugriff (PDF)

FTO blocks RNA translational activity via the loss of N6‐methyladenosine methylation at 5′ UTR regulated by RBM5 in cisplatin‐resistant NSCLC

Journal of cellular physiology, 2024-08, Vol.239 (8), p.e31296-n/a

2024

Volltextzugriff (PDF)

RBM39 enhances cholangiocarcinoma growth through EZH2-mediated WNT7B/β-catenin pathway

Cellular and molecular gastroenterology and hepatology, 2024-09, p.101404, Article 101404

2024

Volltextzugriff (PDF)

Combining DNA Vaccine and AIM2 in H1 Nanoparticles Exert Anti-Renal Carcinoma Effects via Enhancing Tumor-Specific Multi-functional CD8 + T-cell Responses

Molecular cancer therapeutics, 2019-02, Vol.18 (2), p.323-334

2019

Volltextzugriff (PDF)

ISG12a and its interaction partner NR4A1 are involved in TRAIL‐induced apoptosis in hepatoma cells

Journal of cellular and molecular medicine, 2019-05, Vol.23 (5), p.3520-3529

2019

Volltextzugriff (PDF)

Overexpression of RBM34 Promotes Tumor Progression and Correlates with Poor Prognosis of Hepatocellular Carcinoma

Journal of clinical and translational hepatology, 2023-04, Vol.11 (2), p.369-381

2023

Volltextzugriff (PDF)

H1/pAIM2 nanoparticles exert anti‐tumour effects that is associated with the inflammasome activation in renal carcinoma

Journal of cellular and molecular medicine, 2018-11, Vol.22 (11), p.5670-5681

2018

Volltextzugriff (PDF)

miR-942 decreases TRAIL-induced apoptosis through ISG12a downregulation and is regulated by AKT

Oncotarget, 2014-07, Vol.5 (13), p.4959-4971

2014

Volltextzugriff (PDF)

Celecoxib suppresses proliferation and metastasis of pancreatic cancer cells by down-regulating STAT3 / NF-kB and L1CAM activities

Pancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.], 2018-04, Vol.18 (3), p.328-333

2018

Volltextzugriff (PDF)

ISG12a mediates cell response to Newcastle disease viral infection

Virology (New York, N.Y.), 2014-08, Vol.462, p.283-294

2014

Volltextzugriff (PDF)

Msi1 confers resistance to TRAIL by activating ERK in liver cancer cells

FEBS letters, 2015-04, Vol.589 (8), p.897-903

2015

Volltextzugriff (PDF)

1 – 25 von 69

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(59)
Mit Volltextzugriff
(66)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

The RNA methyltransferase METTL16 enhances cholangiocarcinoma growth through PRDM15-mediated FGFR4 expression

The histone lysine acetyltransferase KAT2B inhibits cholangiocarcinoma growth: evidence for interaction with SP1 to regulate NF2-YAP signaling

SNRPB is a mediator for cellular response to cisplatin in non-small-cell lung cancer

Complete replication of hepatitis B virus and hepatitis C virus in a newly developed hepatoma cell line

ISG12a Restricts Hepatitis C Virus Infection through the Ubiquitination-Dependent Degradation Pathway

Pulsed low-dose rate radiotherapy has an improved therapeutic effect on abdominal and pelvic malignancies

MiR-942 mediates hepatitis C virus-induced apoptosis via regulation of ISG12a

Inhibition of hepatitis C virus infection by DNA aptamer against NS2 protein

Improving radio-chemotherapy efficacy of prostate cancer by co-deliverying docetaxel and dbait with biodegradable nanoparticles

Innate host response in primary human hepatocytes with hepatitis C virus infection

2-octynoic acid inhibits hepatitis C virus infection through activation of AMP-activated protein kinase

Inhibition of hepatitis C virus infection by NS5A-specific aptamer

SNRPB promotes the tumorigenic potential of NSCLC in part by regulating RAB26

Systematic pan‐cancer analysis identifies RBM39 as an immunological and prognostic biomarker

Positive feedback loop between cancer stem cells and angiogenesis in hepatocellular carcinoma

FTO blocks RNA translational activity via the loss of N6‐methyladenosine methylation at 5′ UTR regulated by RBM5 in cisplatin‐resistant NSCLC

RBM39 enhances cholangiocarcinoma growth through EZH2-mediated WNT7B/β-catenin pathway

Combining DNA Vaccine and AIM2 in H1 Nanoparticles Exert Anti-Renal Carcinoma Effects via Enhancing Tumor-Specific Multi-functional CD8 + T-cell Responses

ISG12a and its interaction partner NR4A1 are involved in TRAIL‐induced apoptosis in hepatoma cells

Overexpression of RBM34 Promotes Tumor Progression and Correlates with Poor Prognosis of Hepatocellular Carcinoma

H1/pAIM2 nanoparticles exert anti‐tumour effects that is associated with the inflammasome activation in renal carcinoma

miR-942 decreases TRAIL-induced apoptosis through ISG12a downregulation and is regulated by AKT

Celecoxib suppresses proliferation and metastasis of pancreatic cancer cells by down-regulating STAT3 / NF-kB and L1CAM activities

ISG12a mediates cell response to Newcastle disease viral infection

Msi1 confers resistance to TRAIL by activating ERK in liver cancer cells

Suchergebnisse filtern